» Articles » PMID: 21839528

Analysis of Liver Metabolism in a Rat Model of Heart Failure

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2011 Aug 16
PMID 21839528
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cachexia, namely body wasting, is a common complication in cases of congestive heart failure (CHF). Although, neurohumoral and immune abnormalities are associated with the condition, precisely how the imbalance of catabolism and anabolism is responsible for the wasting process is not known.

Methods: We analyzed markers of cachexia in Dahl salt-sensitive rats which show marked hypertension with preserved systolic function at 11 weeks and CHF at 17-19 weeks of age. We also analyzed the change in hepatic metabolism associated with CHF since liver plays a central role in the systemic regulation of catabolism and anabolism.

Results: In CHF rats, a failure to grow was observed and blood hepatic protein levels were decreased associated with increased blood proinflammatory cytokine levels, indicating that Dahl rats serve as a model of cardiac cachexia. Food intake was reduced, and blood sugar and insulin levels were decreased. Despite the apparent fasting condition, blood fatty acid levels were decreased and triglycerides levels were increased. In CHF rats, liver incorporated more glucose, the gene expression related to gluconeogenesis was decreased, the gene expression related to lipogenesis was increased, and the triglyceride content of the liver was increased. The paradoxical production of triglycerides synthesis in fasting rats was associated with a proinflammatory response in liver.

Conclusions: The Dahl salt-sensitive rat can be used as a model of cardiac cachexia. The cachexia was associated with abnormal hepatic metabolism that might work as a maladaptive response during the progression of CHF.

Citing Articles

Effect of an Enteral Formula Enriched With ω-3 Fatty Acids, Carnitine, and Vitamin D on Body Weight, Heart Weight, and Blood Biochemical Parameters in a Dahl Rat Heart Failure Model.

Ryuno Y, Kobayashi J, Fujimoto Y, Dotare T, Matsue Y, Iwanami Y J Cardiovasc Pharmacol. 2024; 84(6):590-598.

PMID: 39326053 PMC: 11617080. DOI: 10.1097/FJC.0000000000001637.


The Network between Heart and Liver from the View of Persian Medicine Versus Conventional Medicine.

Zarei A, Karimi M, Rezaeizadeh H Galen Med J. 2024; 12:e2557.

PMID: 38774840 PMC: 11108664. DOI: 10.31661/gmj.v12i.2557.


Shared genetic architecture and causal relationship between liver and heart disease.

Fang Z, Jia S, Mou X, Li Z, Hu T, Tu Y iScience. 2024; 27(4):109431.

PMID: 38523778 PMC: 10959668. DOI: 10.1016/j.isci.2024.109431.


Direct Bilirubin, but not Indirect Bilirubin, is Associated with Short-term Adverse Events in HFpEF.

Wang S, Chen Y, Ma H, Wang Y, Luo M, Xie X Curr Gene Ther. 2024; 24(4):321-330.

PMID: 38310459 DOI: 10.2174/0115665232273115240102043640.


Metabolic Responses of Normal Rat Kidneys to a High Salt Intake.

Shimada S, Hoffmann B, Yang C, Kurth T, Greene A, Liang M Function (Oxf). 2023; 4(5):zqad031.

PMID: 37575482 PMC: 10413938. DOI: 10.1093/function/zqad031.